window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : November 1, 2025

  • News
  • About Us
Contact Us

Fast Track

  • Biologics & Biosimilars,Biotech,Clinical Development,Pharmaceuticals and therapeutics,Research & Development

    FDA grants Fast Track designation to Enterome’s EO2463 immunotherapy in follicular lymphoma

    Doron Therapeutics has dosed the first patients in its Phase [...]

    October 17, 2025
  • Biologics & Biosimilars,Biotech,Chronic diseases,Clinical Development,Oncology,Pharmaceuticals and therapeutics,Research & Development

    Enterome’s EO2463 receives FDA fast track designation for follicular lymphoma watch-and-wait treatment

    Enterome has received Fast Track designation from the US Food [...]

    October 17, 2025
  • Biologics & Biosimilars,Clinical Development,Drug Development,Rare Diseases,Regulatory Affairs

    FDA grants fast track to Nektar’s rezpegaldesleukin for severe alopecia areata

    Nektar Therapeutics has received FDA Fast Track designation for its [...]

    July 29, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Thermo Fisher Scientific accelerates biologic therapeutics development with new CHO K-1 cell line
    Categories: Biologics & Biosimilars, CDMOs & Manufacturing, Cell & Gene Therapy
  • FairJourney Biologics appoints Werner Lanthaler as chief executive officer
    Categories: Biologics & Biosimilars, Biotech, Movers & Shakers
  • Digital therapeutic cuts schizophrenia’s negative symptoms in trial
    Categories: Clinical Trials, Digital Health, Mental health, Neurosciences
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top